Paid Clinical Trials in Nebraska

Nebraska has 727 paid clinical trials enrolling now across cities including Omaha, Lincoln and Grand Island. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Nebraska include University of Nebraska, National Cancer Institute (NCI) and AstraZeneca, running studies across oncology, cardiology, neurology, and more. The most actively recruiting conditions are Breast Cancer, Non-Small Cell Lung Cancer, Heart Failure, Multiple Myeloma — browse the full list or use the filters to match your diagnosis. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .

Filter results
Filter results
Recruitment status
Phase
Sex
Age

Newly added in Nebraska

Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Drug: Pumitamig
Sites in Omaha, Grand Island +9 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07680764·Phase 2·Recruiting·Listed Jul 2, 2026

656 clinical trials

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

for Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Drug: Nivolumab
Sites in Omaha +33 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT07221149·Phase 2, Phase 3·Recruiting·Listed Oct 2025

Common conditions studied in Nebraska

  • Breast Cancer (18 active studies)
  • Non-Small Cell Lung Cancer (16 active studies)
  • Heart Failure (15 active studies)
  • Multiple Myeloma (15 active studies)
  • Prostate Cancer (14 active studies)
  • Ovarian Cancer (10 active studies)

Leading research sponsors in Nebraska

  • University of Nebraska
  • National Cancer Institute (NCI)
  • AstraZeneca
  • Pfizer
  • AbbVie

Frequently asked questions

How many paid clinical trials are currently recruiting in Nebraska?

There are approximately 727 recruiting clinical trials in Nebraska listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Nebraska pay participants?

Most recruiting trials in Nebraska compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Nebraska?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Nebraska?

The most common conditions under active study in Nebraska include Breast Cancer (18), Non-Small Cell Lung Cancer (16), Heart Failure (15), Multiple Myeloma (15), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Nebraska?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Nebraska on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Nebraska?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Browse more clinical trials

Related healthcare resources in Nebraska

Trials by condition in Nebraska